Claudia Bartels

Summary

Affiliation: Max Planck Institute for Experimental Medicine
Country: Germany

Publications

  1. pmc Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    BMC Neurosci 11:118. 2010
  2. ncbi Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition
    Hannelore Ehrenreich
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    J Ren Nutr 18:146-53. 2008
  3. doi Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes
    Henning Krampe
    Max Planck Institute of Experimental Medicine, Hermann Rein Strasse 3, 37075 Goettingen, Germany
    J Psychiatr Res 43:30-47. 2008
  4. doi Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann Rein Str 3, 37075 Gottingen, Germany
    Neuromuscul Disord 18:398-407. 2008
  5. doi The influence of personality factors on disease progression and health-related quality of life in people with ALS
    Henning Krampe
    Max Planck Institute of Experimental Medicine, Division of Clinical Neuroscience, Goettingen, Germany
    Amyotroph Lateral Scler 9:99-107. 2008
  6. doi Recombinant human erythropoietin in the treatment of acute ischemic stroke
    Hannelore Ehrenreich
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    Stroke 40:e647-56. 2009
  7. pmc Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches
    Martin Begemann
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    Mol Med 14:546-52. 2008
  8. pmc Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    Ther Adv Neurol Disord 1:193-206. 2008
  9. ncbi Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
    Hannelore Ehrenreich
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Georg August University, Gottingen, Germany
    Brain 130:2577-88. 2007
  10. ncbi Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine Hermann Rein Str 3, 37075 Gottingen, Germany
    Alcohol Alcohol 42:92-102. 2007

Detail Information

Publications10

  1. pmc Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    BMC Neurosci 11:118. 2010
    ....
  2. ncbi Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition
    Hannelore Ehrenreich
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    J Ren Nutr 18:146-53. 2008
    ..These promising results are just the beginning and will hopefully stimulate further work along these lines...
  3. doi Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes
    Henning Krampe
    Max Planck Institute of Experimental Medicine, Hermann Rein Strasse 3, 37075 Goettingen, Germany
    J Psychiatr Res 43:30-47. 2008
    ..001). The results suggest to validate the item combination described in the TOPPS in addiction therapy as a treatment guideline of individual relapse prevention strategies...
  4. doi Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann Rein Str 3, 37075 Gottingen, Germany
    Neuromuscul Disord 18:398-407. 2008
    ..The Contralateral Co-Movement Test delivers simple means of symptom quantification, independent of ALS Functional Rating Scale, for future neuroprotective trials...
  5. doi The influence of personality factors on disease progression and health-related quality of life in people with ALS
    Henning Krampe
    Max Planck Institute of Experimental Medicine, Division of Clinical Neuroscience, Goettingen, Germany
    Amyotroph Lateral Scler 9:99-107. 2008
    ..These findings suggest that being less agreeable might serve as a protective factor with respect to QOL and disease progression in ALS...
  6. doi Recombinant human erythropoietin in the treatment of acute ischemic stroke
    Hannelore Ehrenreich
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    Stroke 40:e647-56. 2009
    ..Accordingly, the double-blind, placebo-controlled, randomized German Multicenter EPO Stroke Trial (Phase II/III; ClinicalTrials.gov Identifier: NCT00604630) was designed to evaluate efficacy and safety of EPO in stroke...
  7. pmc Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches
    Martin Begemann
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    Mol Med 14:546-52. 2008
    ..This case suggests that rapid cycling is a systemic disease, resembling hibernation, with prostaglandins playing a mediator role...
  8. pmc Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Gottingen, Germany
    Ther Adv Neurol Disord 1:193-206. 2008
    ..An exploratory study on chronic progressive MS yielded lasting improvement in motor and cognitive performance upon high-dose long-term EPO treatment...
  9. ncbi Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
    Hannelore Ehrenreich
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Georg August University, Gottingen, Germany
    Brain 130:2577-88. 2007
    ..There were no adverse events, no safety concerns and a surprisingly low need of blood-lettings. This first pilot study demonstrates the necessity and feasibility of controlled trials using high-dose rhEPO in chronic progressive MS...
  10. ncbi Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence
    Claudia Bartels
    Division of Clinical Neuroscience, Max Planck Institute of Experimental Medicine Hermann Rein Str 3, 37075 Gottingen, Germany
    Alcohol Alcohol 42:92-102. 2007
    ....